METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Your phone could be your counselor: AI chatbot tested to fight liver disease
Disease control Recruiting nowThis is a small pilot study to see if a chatbot powered by artificial intelligence (AI) is a practical and acceptable tool for helping people with a specific type of fatty liver disease (MetALD) drink less alcohol. The study will recruit 50 adults in Hong Kong who have the diseas…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
First human test for new fatty liver drug begins
Disease control Recruiting nowThis is an early-stage study to test the safety of an experimental drug called ALN-CIDEB in adults with fatty liver disease (MASLD and MASH). The main goal is to see what side effects occur and how the body processes the drug. Researchers will also check if the drug reduces liver…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Stitch in time: new procedure aims to reverse fatty liver disease
Disease control Recruiting nowThis study is testing whether a minimally invasive endoscopic procedure to reduce stomach size, combined with lifestyle changes, is better than lifestyle changes alone for treating a serious fatty liver disease called MASH in people with obesity. Researchers will compare the two …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Major trial aims to stop fatty liver disease from turning deadly
Disease control Recruiting nowThis large study is testing whether two investigational drugs, retatrutide and tirzepatide, can prevent serious liver complications in people with advanced fatty liver disease (MASLD). About 4,500 adults with high-risk liver scarring will be randomly assigned to receive one of th…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Antibiotic tested as new weapon against fatty liver
Disease control Recruiting nowThis early-stage study is testing whether a gut-targeted antibiotic called rifaximin-α can reduce fat buildup in the liver for people with metabolic dysfunction-associated steatotic liver disease (MASLD). Sixty participants will be assigned to take the drug or not for 24 weeks wh…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can an Indian-Style mediterranean diet beat a standard Low-Fat diet for Kids' liver health?
Disease control Recruiting nowThis study aims to find out which of two healthy diets is better at reducing liver fat in overweight children and teenagers with fatty liver disease (MASLD). Researchers will compare a specially adapted Indian version of the Mediterranean diet against a standard low-fat diet over…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Cheaper scan for fatty liver disease? new study puts ultrasound to the test
Diagnosis Recruiting nowThis study is testing a new type of ultrasound scan, called DeepUSFF, to see if it can accurately measure fat in the liver. Researchers will compare the results from this new ultrasound to the results from a more expensive and less available MRI scan, which is currently a top met…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Apr 02, 2026 07:27 UTC
-
Silent liver disease epidemic: can a simple computer alert help doctors spot it?
Diagnosis Recruiting nowThis study is testing a new computer alert system designed to help primary care doctors better identify patients with fatty liver disease (MASLD) who are at risk for serious liver scarring. The system works quietly in the background of electronic health records, prompting doctors…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
New scan could spare kids painful liver biopsies
Diagnosis Recruiting nowThis study is testing a new, non-invasive ultrasound device called Velacur to see if it can accurately detect fatty liver disease in children and teens. Researchers want to see if this quick, bedside test can work as well as current gold-standard methods like MRI or liver biopsy,…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Can a menopause drug unlock secrets to fatty liver disease?
Knowledge-focused Recruiting nowThis study aims to understand if a drug that temporarily stops menstrual cycles (causing a reversible, drug-induced menopause) affects fat buildup in the liver. It will observe 62 women with endometriosis, comparing those who receive the drug after surgery to those who do not. Th…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE4 • Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists probe hidden link between liver health and kidney stone risk
Knowledge-focused Recruiting nowThis study aims to understand if a common liver condition (MASLD) changes how much oxalate the body makes on its own. Oxalate is a natural substance that, in high amounts, can contribute to kidney stones. Researchers will measure this by having 28 participants follow a special lo…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Major study launches to unlock secrets of diabetes and liver disease link
Knowledge-focused Recruiting nowThis study aims to create a detailed registry of 1000 people in Hong Kong who have both Type 2 diabetes and fatty liver disease (MASLD). Researchers will follow participants over time to understand how these two common conditions affect each other and progress. The main goal is t…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Scientists probe hidden cellular links in liver disease
Knowledge-focused Recruiting nowThis study aims to understand how communication between different parts of cells changes in people with fatty liver disease (MASH). Researchers will examine liver and blood samples from 20 patients undergoing weight-loss surgery to see if these cellular changes are linked to dise…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC